GLP-1 Market Trends and Global Forecasts 2025-2035: 150+ Candidates Intended for the Treatment of Multiple Indications, are Currently Either Approved or Being Investigated ...

Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...

GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 - Landscape Led by China and the U.S., Rising Partnerships, and Strong DTC-Driven Demand Push ...

The GLP-1 market is primed for substantial growth due to rising obesity and diabetes rates. Opportunities lie in expanding drug applications beyond diabetes, focusing on weight management in ...
The American Journal of Managed Care

GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin

Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...
Healio

Liraglutide, dulaglutide present similar efficacy as semaglutide in CV, kidney outcomes

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...
The White House

Statements of Administration Policy

H.R. 875 – Jeremy and Angel Seay and Sergeant Brandon Mendoza Protect Our Communities from DUIs Act of 2025 (June 24, 2025) H.R. 275 – Special Interest Alien Reporting Act of 2025 (June 24, 2025) S.J.
pharmaphorum

FDA approves MACE label claim for Lilly’s Trulicity

Eli Lilly has firmed up the label for its type 2 diabetes therapy Trulicity with FDA approval for a new cardiovascular risk reduction claim, as it faces increased competition from Novo Nordisk. The US ...